Matches in SemOpenAlex for { <https://semopenalex.org/work/W2333178407> ?p ?o ?g. }
- W2333178407 endingPage "S689" @default.
- W2333178407 startingPage "S689" @default.
- W2333178407 abstract "To demonstrate in vitro in vivo epidermal growth factor receptor (EGFR) targeting specificity of a multifunctional molecular probe by combining the receptor-targeting monoclonal antibody (mAb) with the contrast agent Gadolinium (Gd). The molecular probe was comprised of two functional subunits, anti-EGFR antibodies for tumor targeting and dendrimer nanoclusters (DNCs) loaded with Gd for MR image contrast. Gd was tethered to the DNCs by Diethylene Triamine Pentaacetic Acid (DTPA) anhydride in alkaline condition. Avidin, a tetrameric biotin-binding protein, was added to biotinylated anti-EGFR mAb (C225) and biotinylated Gd-DNC, producing the multifunctional probe. The probe was tested for its targeting specificity in vitro and in vivo. The target (human head and neck cancer 15B) and the control HEK293 cells were cultured and the probe was mixed with the fixed cells to allow target-probe binding, followed by multiple PBS washes to remove any unbound probe. Flow cytometry and MR imaging were performed to verify cell targeting and reduction in T1 relaxation times, respectively. The shift in fluorescent intensity (SFI) was used to determine the relative EGFR expression level and the cell targeting ability of the probe. T1 relaxation times as a function of different probe concentrations were determined by an inversion recovery fast spin echo imaging sequence on a 3T MR system at 25oC with the following settings: TE = 12ms, TR = 6000ms, inversion time, TI = 40-2800ms. Binding specificity of the probe in vivo was tested in the nude mice who were implanted with 15B xenografts and imaged under MR to observe region-of-interest specific uptake following injection of the probe via the tail vein. Flow cytometry data revealed high targeted binding affinity of the probe to 15B (SFI = 1,800) and low affinity to HEK293 (SFI = 300), representing the functionality and specificity of the probe at the molecular level. Sample T1 relaxation times in vitro were 1,600 ms, 1,100 ms, and 450 ms for cells without any probe, HEK293 with probe, and 15B with probe, respectively. The tumor region of interest (ROI) showed strong contrast enhancement following a tail vein injection of the probe. A time course measurement of contrast showed that the image contrast (IC) in the tumor ROI region increased substantially in the first 5 mins after probe injection and kept stable thru the first 40 mins relative to IC in the non-tumor ROI. In a control experiment, IC increased on the mouse injected with the same dose of Gd-DTPA, but subsided after 5 mins. We have developed an EGFR targeting and imaging probe by combining the therapeutic antibody and diagnostic contrast agent Gd for MR imaging. The probe is able to selectively target the EGFR receptor and allow drug uptake to be imaged." @default.
- W2333178407 created "2016-06-24" @default.
- W2333178407 creator A5000500792 @default.
- W2333178407 creator A5014572211 @default.
- W2333178407 creator A5016575003 @default.
- W2333178407 creator A5037814677 @default.
- W2333178407 creator A5063457618 @default.
- W2333178407 creator A5064301133 @default.
- W2333178407 creator A5069852433 @default.
- W2333178407 creator A5083023771 @default.
- W2333178407 date "2012-11-01" @default.
- W2333178407 modified "2023-10-18" @default.
- W2333178407 title "Multifunctional Molecular Probes for Targeting and Imaging of Epidermal Growth Factor Receptor" @default.
- W2333178407 doi "https://doi.org/10.1016/j.ijrobp.2012.07.1840" @default.
- W2333178407 hasPublicationYear "2012" @default.
- W2333178407 type Work @default.
- W2333178407 sameAs 2333178407 @default.
- W2333178407 citedByCount "0" @default.
- W2333178407 crossrefType "journal-article" @default.
- W2333178407 hasAuthorship W2333178407A5000500792 @default.
- W2333178407 hasAuthorship W2333178407A5014572211 @default.
- W2333178407 hasAuthorship W2333178407A5016575003 @default.
- W2333178407 hasAuthorship W2333178407A5037814677 @default.
- W2333178407 hasAuthorship W2333178407A5063457618 @default.
- W2333178407 hasAuthorship W2333178407A5064301133 @default.
- W2333178407 hasAuthorship W2333178407A5069852433 @default.
- W2333178407 hasAuthorship W2333178407A5083023771 @default.
- W2333178407 hasBestOaLocation W23331784071 @default.
- W2333178407 hasConcept C121332964 @default.
- W2333178407 hasConcept C121608353 @default.
- W2333178407 hasConcept C12554922 @default.
- W2333178407 hasConcept C126322002 @default.
- W2333178407 hasConcept C136339569 @default.
- W2333178407 hasConcept C145169222 @default.
- W2333178407 hasConcept C150903083 @default.
- W2333178407 hasConcept C153911025 @default.
- W2333178407 hasConcept C159654299 @default.
- W2333178407 hasConcept C170493617 @default.
- W2333178407 hasConcept C185592680 @default.
- W2333178407 hasConcept C202751555 @default.
- W2333178407 hasConcept C203014093 @default.
- W2333178407 hasConcept C204628709 @default.
- W2333178407 hasConcept C207001950 @default.
- W2333178407 hasConcept C2776362946 @default.
- W2333178407 hasConcept C2779438470 @default.
- W2333178407 hasConcept C2780306303 @default.
- W2333178407 hasConcept C542903549 @default.
- W2333178407 hasConcept C552990157 @default.
- W2333178407 hasConcept C553184892 @default.
- W2333178407 hasConcept C55493867 @default.
- W2333178407 hasConcept C57477423 @default.
- W2333178407 hasConcept C62520636 @default.
- W2333178407 hasConcept C71924100 @default.
- W2333178407 hasConcept C86803240 @default.
- W2333178407 hasConcept C91881484 @default.
- W2333178407 hasConcept C96232424 @default.
- W2333178407 hasConceptScore W2333178407C121332964 @default.
- W2333178407 hasConceptScore W2333178407C121608353 @default.
- W2333178407 hasConceptScore W2333178407C12554922 @default.
- W2333178407 hasConceptScore W2333178407C126322002 @default.
- W2333178407 hasConceptScore W2333178407C136339569 @default.
- W2333178407 hasConceptScore W2333178407C145169222 @default.
- W2333178407 hasConceptScore W2333178407C150903083 @default.
- W2333178407 hasConceptScore W2333178407C153911025 @default.
- W2333178407 hasConceptScore W2333178407C159654299 @default.
- W2333178407 hasConceptScore W2333178407C170493617 @default.
- W2333178407 hasConceptScore W2333178407C185592680 @default.
- W2333178407 hasConceptScore W2333178407C202751555 @default.
- W2333178407 hasConceptScore W2333178407C203014093 @default.
- W2333178407 hasConceptScore W2333178407C204628709 @default.
- W2333178407 hasConceptScore W2333178407C207001950 @default.
- W2333178407 hasConceptScore W2333178407C2776362946 @default.
- W2333178407 hasConceptScore W2333178407C2779438470 @default.
- W2333178407 hasConceptScore W2333178407C2780306303 @default.
- W2333178407 hasConceptScore W2333178407C542903549 @default.
- W2333178407 hasConceptScore W2333178407C552990157 @default.
- W2333178407 hasConceptScore W2333178407C553184892 @default.
- W2333178407 hasConceptScore W2333178407C55493867 @default.
- W2333178407 hasConceptScore W2333178407C57477423 @default.
- W2333178407 hasConceptScore W2333178407C62520636 @default.
- W2333178407 hasConceptScore W2333178407C71924100 @default.
- W2333178407 hasConceptScore W2333178407C86803240 @default.
- W2333178407 hasConceptScore W2333178407C91881484 @default.
- W2333178407 hasConceptScore W2333178407C96232424 @default.
- W2333178407 hasIssue "3" @default.
- W2333178407 hasLocation W23331784071 @default.
- W2333178407 hasOpenAccess W2333178407 @default.
- W2333178407 hasPrimaryLocation W23331784071 @default.
- W2333178407 hasRelatedWork W2008935100 @default.
- W2333178407 hasRelatedWork W2010201035 @default.
- W2333178407 hasRelatedWork W2033564498 @default.
- W2333178407 hasRelatedWork W2062607858 @default.
- W2333178407 hasRelatedWork W2122411931 @default.
- W2333178407 hasRelatedWork W2153592609 @default.
- W2333178407 hasRelatedWork W2188879094 @default.
- W2333178407 hasRelatedWork W2198850752 @default.
- W2333178407 hasRelatedWork W3033118196 @default.
- W2333178407 hasRelatedWork W2609102462 @default.